title: Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus.
abstract: OBJECTIVE
  To study the patterns of hypoglycaemic treatment in our community and to estimate the prevalence of known and drug-treated diabetes mellitus.
  
  
  METHODS
  From all the diabetic patients who attended the Healthcare Centers of the National Health Service in Gran Canaria in 1999, a random sample of 2924 diabetic patients > 20 years old was selected. Data on age, gender, clinical onset of diabetes, and hypoglycaemic treatment were obtained. Data on drug consumption were supplied by the National Health Service.
  
  
  RESULTS
  Of the DM-2 patients 4.4% (3.65-5.14) 84.2% (82.7785.42), 9.4% (8.34-10.45) and 2.1% (1.58-2.61) received diet only, oral drugs, insulin or combination. The duration of DM-2 was associated with more oral drugs and more insulin treatment, but the duration of DM-1 was not associated with intensive insulin therapy;<50% of the type 1 patients had >or=3 daily injections. The prescriptions of biguanides were scarce; over 1/3 of them were of buformin. DM-1 and DM-2 patients were treated with similar doses of insulin, but DM-1 patients had more insulin injections (2.56 vs 2.07, P<0.001), and more fast-acting insulins (65.2% vs 38.0%, P<0.001). The estimated prevalences of known and drug-treated diabetes in the Gran Canaria island were 5.95% (95% CI: 5.096.80%) and 5.73% (4.88-6.57%).
  
  
  CONCLUSIONS
  Our prevalences of known and drug-treated diabetes is among the highest reported in European populations. The prescriptions of metformin and of combined therapy in DM-2, and of intensive insulin therapy in DM-1 are less frequent than expected, but nonetheless insulin therapy in DM-1 is more intensive and uses more fast-acting insulin than in DM-2.
authors.affiliation: Departmentt of Endocrinology, Hospital Dr Negrín, Spain. ppabvel@gobiernodecanarias.org
authors.forename: P L
authors.initials: PL
authors.lastname: de Pablos-Velasco
authors.forename: F J
authors.initials: FJ
authors.lastname: Martínez-Martín
authors.forename: R
authors.initials: R
authors.lastname: Molero
authors.forename: F
authors.initials: F
authors.lastname: Rodríguez-Perez
authors.forename: I
authors.initials: I
authors.lastname: García-Puente
authors.forename: A
authors.initials: A
authors.lastname: Caballero
mesh_terms: D000328:Adult; D001266:Atlantic Islands / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000453:epidemiology*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D013030:Spain / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin